Literature DB >> 29768547

Clinical outcomes and risk factors for death from disseminated histoplasmosis in patients with AIDS who visited a high-complexity hospital in Campo Grande, MS, Brazil.

Barbara Cristina Scarcelli Boigues1, Anamaria Mello Miranda Paniago1, Gláucia Moreira Espíndola Lima2, Maina de Oliveira Nunes2, Silvia Naomi de Oliveira Uehara1.   

Abstract

INTRODUCTION: Disseminated histoplasmosis (DH) is a systemic mycosis caused by Histoplasma capsulatum (H. capsulatum) and is characterized by progressive and fatal evolution in immunocompromised patients. Moreover, it is considered an AIDS-defining disease.
METHODS: We performed an observational, analytical, retrospective study to identify the clinical outcomes and risk factors for death from DH in patients with AIDS at an infectious diseases service facility in Brazil between September 2011 and July 2016. Patients with a positive serology for HIV and DH were diagnosed via direct examination and/or positive cultures for H. capsulatum.
RESULTS: Twenty-three patients were included in this study. Approximately, 82.6% were men, with a mean age of 41.0±11.5 years, and 52.2% had a concomitant diagnosis of AIDS and DH. The median CD4+ T cell count was 19 cells/mm3, and 56.5% of the patients died. The most frequently observed symptoms were fever, dyspnea, and skin lesions. On the basis of a comparative analysis of those who died and survived, the absence of splenomegaly and hepatomegaly and the presence of H. capsulatum in the peripheral blood were considered as risk factors for death. Those who died had a higher leukocyte count; CRP, urea, and lactate dehydrogenase levels; AST index; and international normalized ratio prothrombin time. The serum total protein and albumin levels of the patients were lower.
CONCLUSIONS: The mortality rate for DH is high among severely immunocompromised patients with AIDS. The risk factors for death were those traditionally associated with blood dyscrasia, inflammatory activity, as well as increased renal and nutritional impairment.

Entities:  

Mesh:

Year:  2018        PMID: 29768547     DOI: 10.1590/0037-8682-0369-2017

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  5 in total

Review 1.  Histoplasmosis and Tuberculosis Co-Occurrence in People with Advanced HIV.

Authors:  Diego H Caceres; Audrey Valdes
Journal:  J Fungi (Basel)       Date:  2019-08-09

2.  Histoplasmosis, An Underdiagnosed Disease Affecting People Living With HIV/AIDS in Brazil: Results of a Multicenter Prospective Cohort Study Using Both Classical Mycology Tests and Histoplasma Urine Antigen Detection.

Authors:  Diego R Falci; Alexandre A Monteiro; Cassia Ferreira Braz Caurio; Tulio C O Magalhães; Melissa O Xavier; Rossana P Basso; Marineide Melo; Alexandre V Schwarzbold; Paulo Roberto Abrão Ferreira; Jose Ernesto Vidal; João Paulo Marochi; Cassia Silva de Miranda Godoy; Renata de Bastos Ascenco Soares; Aurea Paste; Monica B Bay; Vera Lucia Pereira-Chiccola; Lisandra Serra Damasceno; Terezinha do Menino Jesus Silva Leitão; Alessandro C Pasqualotto
Journal:  Open Forum Infect Dis       Date:  2019-04-13       Impact factor: 3.835

3.  Intracranial hemorrhage secondary to disseminated histoplasmosis in AIDS: an uncommon presentation.

Authors:  Raquel Silveira Bello Stucchi; Athanase Billis; Fabiano Reis
Journal:  Rev Soc Bras Med Trop       Date:  2021-03-22       Impact factor: 1.581

Review 4.  Histoplasmosis overlapping with HIV and tuberculosis in sub-Saharan Africa: challenges and research priorities.

Authors:  Marius Paulin Ngouanom Kuate; Bassey Ewa Ekeng; Richard Kwizera; Christine Mandengue; Felix Bongomin
Journal:  Ther Adv Infect Dis       Date:  2021-04-09

5.  Long-Term Mortality after Histoplasma Infection in People with HIV.

Authors:  Joseph Cherabie; Patrick Mazi; Adriana M Rauseo; Chapelle Ayres; Lindsey Larson; Sasinuch Rutjanawech; Jane O'Halloran; Rachel Presti; William G Powderly; Andrej Spec
Journal:  J Fungi (Basel)       Date:  2021-05-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.